AB Science reports its revenues for the year 2023 and provides an update on its activities marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
AB Science is up over 5% after the pharmaceutical company announced that it had successfully appealed to the Paris Court of Appeal against the decision of the AMF s Enforcement Committee on March 24,.
PRESS RELEASE THE PARIS COURT OF APPEAL CONFIRMS THE ACQUITTAL OF THE CEO OF AB SCIENCE, ALAIN MOUSSY, AND REDUCES THE AMOUNT OF THE FINANCIAL PENALTY IMPOSED ON AB SCIENCE Paris, May 2, 2024, 7pm.
PRESS RELEASE NEW RESEARCH SHOWS THAT MASITINIB LIMITS NEURONAL DAMAGE IN A MODEL OF NEUROIMMUNE-DRIVEN NEURODEGENERATIVE DISEASE THIS IS THE FIRST DEMONSTRATION THAT MASITINIB CAN LOWER SERUM.
AB Science has announced that the European Patent Office has issued a Notice of Allowance for a method patent for the treatment of severe systemic mastocytosis with its lead compound, masitinib. This.